Botox Injections: Option for Urge Incontinence?

The drug worked as well as standard pills in head-to-head study, but is not fully approved for that use

October 4, 2012 RSS Feed Print

Allergan, which makes Botox, has now asked the FDA for approval for adults with idiopathic urge incontinence for whom standard medicines don't work, said company spokeswoman Heather Katt. Allergan declined to estimate costs of the injections for urge incontinence, but Katt said many plans cover the treatment for neurogenic urge incontinence and also would be expected to do so for the new indication, if it is approved.

The U.S. National Institutes of Health funded the study. Visco has no pharmaceutical company ties to report. Some co-authors report serving as consultants for Astellas Pharma US and GlaxoSmithKline, which make Vesicare.

More information

To learn more about incontinence, visit the U.S. National Institutes of Health.